← back to search

Harry Bartelink

The Netherlands Cancer Institute · NL
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Advanced Radiotherapy Techniques, and Breast Implant and Reconstruction.
h-index
88
citations
37,584
works
455
NIH funding
primary concept
Medicine
email

Recent publications

A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)
Radiotherapy and Oncology 2024cited by 18position: middledoi
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925
Radiotherapy and Oncology 2023cited by 12position: middledoi
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925
JNCI Journal of the National Cancer Institute 2021cited by 48position: middledoi
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial
The Lancet Oncology 2020cited by 283position: lastdoi
Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial
International Journal of Radiation Oncology*Biology*Physics 2020cited by 54position: middledoi
Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer.
Journal of Clinical Oncology 2018cited by 15position: lastdoi
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial
JAMA Oncology 2016cited by 141position: lastdoi
PO-0674: Factors influencing patient reported cosmetic outcome: results of the Young Boost Trial
Radiotherapy and Oncology 2016cited by 1position: middledoi
First results of the preoperative accelerated partial breast irradiation (PAPBI) trial
Radiotherapy and Oncology 2015cited by 73position: middledoi
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
The Lancet Oncology 2014cited by 677position: firstdoi
Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis
Breast Cancer Research and Treatment 2014cited by 60position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Philip Poortmans · Ziekenhuisnetwerk Antwerpen Stuivenberg7 papers (2014–2023)H. Struikmans · Leiden University Medical Center6 papers (2014–2023)Alain Fourquet · Institut Curie6 papers (2014–2023)Sofía Rivera · Institut Gustave Roussy5 papers (2015–2023)Caroline Weltens · European Organisation for Research and Treatment of Cancer5 papers (2014–2023)Paula H.M. Elkhuizen · Canisius-Wilhelmina Ziekenhuis5 papers (2014–2020)Femke van der Leij · Utrecht University5 papers (2015–2023)Matthias Gückenberger · Stadtspital Waid4 papers (2018–2023)Volker Budach · Freie Universität Berlin4 papers (2018–2023)Carine Kirkove · Cliniques Universitaires Saint-Luc4 papers (2018–2023)K. Peignaux-Casasnovas · European Organisation for Research and Treatment of Cancer4 papers (2018–2023)Ernest Vonk · Radiotherapie Groep4 papers (2018–2023)Peter De Brouwer · Instituut Verbeeten3 papers (2020–2023)Emiel J. Rutgers · Oncode Institute3 papers (2014–2020)Jelle Wesseling · Leiden University Medical Center3 papers (2014–2020)Sandra Collette · European Organisation for Research and Treatment of Cancer3 papers (2014–2018)Geertjan van Tienhoven · Dutch Cancer Society3 papers (2018–2023)Mariacarla Valli · Ente Ospedaliero Cantonale3 papers (2020–2023)N. Weidner · European Organisation for Research and Treatment of Cancer3 papers (2020–2023)Eveline Koiter · Medisch Spectrum Twente3 papers (2020–2023)